How GLP-1 care actually works.
Plain-language explainers for the questions patients and clinicians actually ask — pricing, pharmacy pathways, dose escalation, side-effect management, switching providers.
503A vs 503B pharmacies: what the difference actually means for your medication
503A and 503B are two different regulatory pathways under which a compounding pharmacy can prepare your medication. The difference matters for safety, quality, and what your provider should be willing to disclose.
Tirzepatide vs semaglutide: the head-to-head, simplified
The two dominant GLP-1 therapies differ in mechanism, magnitude of effect, and side-effect profile. Here's how to think about which one fits.
How to choose a GLP-1 telehealth provider: a six-pillar checklist
The factors that actually distinguish a good GLP-1 telehealth program from a marketing-heavy one — distilled into a practical checklist.
What labs you'll need before starting GLP-1 treatment
The standard baseline lab panel before starting a GLP-1, what each test screens for, and what to expect for follow-up.
Managing GLP-1 side effects: a practical playbook
Most GLP-1 side effects are GI, predictable, and manageable. Here's the practical playbook for getting through dose escalation.
Switching telehealth providers without disrupting your treatment
How to switch from one GLP-1 telehealth program to another while maintaining dose continuity and avoiding the common transition pitfalls.
Insurance coverage for GLP-1s: the realistic landscape
Coverage for GLP-1s varies dramatically by indication, payer, and employer benefit design. Here's the realistic landscape.
Compounded vs brand-name GLP-1: what you're actually buying
A direct comparison of what compounded and brand-name GLP-1 medications are — and what they aren't.
The GLP-1 dose ladder, explained
Why GLP-1 dosing starts low and climbs slowly — and what the typical schedule looks like for semaglutide and tirzepatide.
Cold-chain shipping: how your GLP-1 actually gets to you
GLP-1 medications require refrigeration. How cold-chain shipping works, what can go wrong, and what to look for.
Maintaining results after reaching goal weight on GLP-1
Stopping GLP-1 therapy after reaching goal weight typically leads to regain. Here's what the data show and how to plan.
BMI eligibility for GLP-1 weight-loss treatment
The BMI thresholds in FDA labeling, how clinicians actually apply them, and what to do if you're close to a threshold.